Jay S. Duker, MD, is the President & CEO and Board Director of EyePoint Pharmaceuticals, a biopharmaceutical company that develops sustained-release medications to treat serious ocular disorders. Dr. Duker has devoted more than 30 years to the field of ophthalmology focused on improving eyesight and preventing blindness, holding roles in clinical research, business, and academic settings. Dr. Duker joined EyePoint in 2020. Prior to becoming President & CEO in July 2023, Dr. Duker served EyePoint as President and Chief Operating Officer, and as Chief Strategic Scientific Officer. He also served on EyePoint’s Board of Directors from 2016-2020 prior to his re-appointment to the Board of Directors in July 2023.